InsideTrading SEC Form 4 insider trades

Stocks

BLTE BELITE BIO, INC

Healthcare · Pharmaceutical Preparations · Market cap: $6.5B

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $0, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $0 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $8.5M 2026-Q3: bought $0, sold $32.0M 2026-Q4: bought $0, sold $82.7K
Bought, above the line (largest quarter $0) Sold, below the line (largest quarter $32.0M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$0$0
2024-Q3$0$0
2024-Q4$0$0
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$0$0
2026-Q1$0$0
2026-Q2$0$8.5M
2026-Q3$0$32.0M
2026-Q4$0$82.7K

Insider activity

Download CSV Up to 5,000 rows
Bought$00 buy days
Sold$40.6M29 sell days
Net insider flow-$40.6Mnet selling · 5 years
Latest trade2026-10-01Scholl Hendrik Peter
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-10-01 Sell Scholl Hendrik Peter Other C-suite 500 $165.32 $82.7K 8
2026-09-08 Sell Lin Yu-Hsin CEO 26,000 $196.56 $5.1M 5
2026-09-08 Sell Chuang Hao-Yuan CFO 17,962 $196.42 $3.5M 5
2026-09-04 Sell Lin Yu-Hsin CEO 74,435 $187.71 $14.0M 14
2026-09-04 Sell Chuang Hao-Yuan CFO 49,433 $187.64 $9.3M 14
2026-08-12 Sell Chuang Hao-Yuan CFO 367 $180.35 $66.2K 2
2026-08-12 Sell Lin Yu-Hsin CEO 365 $180.35 $65.8K 2
2026-06-18 Sell Scholl Hendrik Peter Other C-suite 10,000 $145.24 $1.5M 5
2026-06-16 Sell Scholl Hendrik Peter Other C-suite 10,000 $140.57 $1.4M 8
2026-05-07 Sell MATA NATHAN L. Other C-suite 666 $153.21 $102.0K 4
2026-05-06 Sell MATA NATHAN L. Other C-suite 1,000 $153.84 $153.8K 6
2026-05-05 Sell MATA NATHAN L. Other C-suite 1,000 $155.50 $155.5K 6
2026-05-04 Sell MATA NATHAN L. Other C-suite 1,000 $155.64 $155.6K 5
2026-05-01 Sell MATA NATHAN L. Other C-suite 1,000 $155.78 $155.8K 8
2026-04-30 Sell MATA NATHAN L. Other C-suite 1,000 $156.97 $157.0K 4
2026-04-29 Sell MATA NATHAN L. Other C-suite 1,000 $155.82 $155.8K 5
2026-04-28 Sell MATA NATHAN L. Other C-suite 1,000 $159.16 $159.2K 9
2026-04-27 Sell MATA NATHAN L. Other C-suite 1,000 $162.64 $162.6K 5
2026-04-24 Sell MATA NATHAN L. Other C-suite 1,000 $159.56 $159.6K 6
2026-04-23 Sell MATA NATHAN L. Other C-suite 1,000 $166.28 $166.3K 6
2026-04-22 Sell MATA NATHAN L. Other C-suite 1,000 $170.39 $170.4K 9
2026-04-21 Sell MATA NATHAN L. Other C-suite 1,000 $166.00 $166.0K 5
2026-04-20 Sell MATA NATHAN L. Other C-suite 1,000 $163.60 $163.6K 7
2026-04-17 Sell MATA NATHAN L. Other C-suite 1,000 $161.63 $161.6K 6
2026-04-16 Sell MATA NATHAN L. Other C-suite 1,000 $160.38 $160.4K 7
2026-04-15 Sell MATA NATHAN L. Other C-suite 1,000 $168.30 $168.3K 5
2026-04-09 Sell Lin Yu-Hsin CEO 9,200 $181.45 $1.7M 4
2026-04-09 Sell Chuang Hao-Yuan CFO 6,200 $181.50 $1.1M 4
2026-04-09 Sell Chen Wan-Shan Director 1,100 $180.43 $198.5K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Lin Yu-Hsin CEO $0 $20.8M 2026-09-08
Chuang Hao-Yuan CFO $0 $14.0M 2026-09-08
Scholl Hendrik Peter Other C-suite $0 $2.9M 2026-10-01
MATA NATHAN L. Other C-suite $0 $2.7M 2026-05-07
Chen Wan-Shan Director $0 $198.5K 2026-04-09

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

No buying cluster has formed at this company.

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.